Regulation2025.04.18
Minnesota recreational program clears final implementation rules
Adult-use sales schedule confirmed for late summer with tiered tax structure and microbusiness license tier.
— OpenStates
Terminal V.2.4 // Encrypted Botanical Stream
High
Culture
Data.
Independent cannabis commerce intelligence. Aggregated from public dispensary registries, retail menus, and state regulatory filings — decrypted into a single terminal. We do not sell. We reveal.
SpecimenX-77 / VG
StatusCultivating
///IL+2.4%///CA-1.1%///MI+0.8%///NY—///FL+4.2%///MA-0.4%///CO+1.9%///WA+0.3%///NV-2.0%///OR+1.2%///AZ+0.6%///MNNEW///IL+2.4%///CA-1.1%///MI+0.8%///NY—///FL+4.2%///MA-0.4%///CO+1.9%///WA+0.3%///NV-2.0%///OR+1.2%///AZ+0.6%///MNNEW
Five instruments,
one terminal.
Each module aggregates public-record data into actionable cannabis intelligence.
/01→ ENTER
Locator.
Dispensary network finder by ZIP code, state, license tier and delivery type.
/02→ ENTER
Index.
Live retail price comparison by strain, format and territory.
/03→ ENTER
Jurisdiction.
State-by-state legality, tax burden and regulatory program timelines.
/04→ ENTER
Archive.
Curated strain database — lineage, terpene profile and effect mapping.
/05→ ENTER
Dispatch.
Federal & state legalization updates and market-moving developments.
The Archive.
[ View all 14,204 cultivars → ]Jurisdiction
Index.
Real-time regulatory status and spot pricing across monitored territories. Data secured via state registries and public retail menus.
Open full map →Territory
Status
Tax Burden
Spot / Oz
California
Recreational
15% State + Local
$214.50
Colorado
Recreational
15% Excise + 2.9%
$178.00
Florida
Medical
No Excise
$268.40
Illinois
Recreational
10–25% Tiered
$312.20
Massachusetts
Recreational
10.75% State
$256.10
Michigan
Recreational
10% Excise + 6%
$88.90
Dispatch.
[ Full feed → ]Market2025.04.17
California spot prices fall 1.1% on Q1 cultivation surplus
Greenhouse oversupply in the Salinas region pushes wholesale flower to a 36-month low.
— Index Wire
Science2025.04.15
Caryophyllene pathway studied as anti-inflammatory mechanism
Peer-reviewed work clarifies the CB2-receptor activity of the dominant terpene in indica lineages.
— Journal Excerpt